|
Advances in the Treatment of Chronic Myelogenous LeukemiaImproving Cancer Care Through Nursing Research and Patient OutcomesLung Cancer Screening and Prevention: Are We Reducing Lung Cancer Mortality?Management of Tumor Lysis SyndromeManaging Effects of Cancer Therapy: LymphedemaNCCN 2nd Annual Congress: Hematologic Malignancies
Blood Products and Growth Factors in the Treatment of ThrombocytopeniaNCCN 2nd Annual Congress: Hematologic Malignancies
Cutaneous T-Cell LymphomaNCCN 2nd Annual Congress: Hematologic Malignancies
Initial and Subsequent Lines of Treatment in Multiple MyelomaNCCN 2nd Annual Congress: Hematologic Malignancies
Managing Infections in Patients with Hematologic MalignanciesNCCN 2nd Annual Congress: Hematologic Malignancies
Multiple Myeloma: How to Treat Patients that Progress or RelapseNCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Implications of the 2008 WHO ReclassificationNCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Treatment by Risk GroupsNCCN 2nd Annual Congress: Hematologic Malignancies
Myelodysplastic Syndromes: Who Would Benefit From Immunosuppressive Therapy?NCCN 2nd Annual Congress: Hematologic Malignancies
Non-Hodgkin’s Lymphoma: Low-Grade LymphomasNCCN 2nd Annual Congress: Hematologic Malignancies
Non-Hodgkin’s Lymphoma: Mantle Cell LymphomaNCCN 2nd Annual Congress: Hematologic Malignancies
Skeletal ComplicationsNCCN 2nd Annual Congress: Hematologic Malignancies
Transfusion Support and Iron Overload in Myelodysplastic SyndromesNCCN 2nd Annual Congress: Hematologic Malignancies
Treatment of Acute Myeloid LeukemiaNCCN 2nd Annual Congress: Hematologic Malignancies
Treatment of Systemic Light Chain AmyloidosisNCCN 2nd Annual Congress: Hematologic Malignancies
Tumor Lysis SyndromeNCCN 2nd Annual Congress: Hematologic Malignancies
Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous LeukemiaNCCN Breast Cancer Guidelines UpdateNCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Adjuvant Therapy: Chemotherapy, Hormonal TherapyNCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Primary Treatment:
Update on Sentinel Node Biopsy and Axillary Dissection, Surgery, and RadiationNCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Prognostic FactorsNCCN Clinical Practice Guidelines in Oncology Symposium: Breast Cancer - Treatment for Advanced Breast Cancer: Chemotherapy, Biologic Therapy, Hormonal TherapyNCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
Emerging IssuesNCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
Initial Evaluation of Renal Cell Carcinoma and Surgical Management of Resectable DiseaseNCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
New Paradigms for the Management of Unresectable and Recurrent Renal Cell CarcinomaNCCN Clinical Practice Guidelines in Oncology Symposium: Kidney Cancer –
The Role of Cytokine Therapy in Unresectable or Recurrent Renal Cell CarcinomaNCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer - Neoadjuvant Combined Modality Therapy for Potentially Resectable Stage III Non-Small Cell Lung CancerNCCN Clinical Practice Guidelines in Oncology Symposium: Non-Small Cell Lung Cancer -
Treatment Options for Unresectable Stage III Non-Small Cell Lung CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Adjuvant Therapy for Locoregional Colon CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Management of Anal CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Surgical Approaches to Rectal CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Colon, Rectal, & Anal Cancers – Therapy for Advanced DiseaseNCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Management of Metastatic Non-Small Cell Lung CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Therapy for Stages I, IIA, IIB, and IIIA (T3, N1) Non-Small Cell Lung CancerNCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer - Workup, Prognostic Factors, and MarkersNCCN Clinical Practice Guidelines in Oncology Symposium:
Non-Small Cell Lung Cancer – Novel Agents for the Therapy of Lung CancerNCCN Non-Small Cell Lung Cancer Guidelines UpdateNCCN Prevention and Treatment of Cancer-Related Infections Guidelines UpdateNCCN Task Force Report: Gastrointestinal Stromal Tumors (GISTs)Prophylactic Therapy: Identifying Patients at Risk for Fever and NeutropeniaQuality of Life Decisions and Treatment Options for Localized Prostate CancerRecognition and Management of Delirium in Cancer Patients Roundtable: Cancer Care – Cost, Access, and ValueRoundtable: The Role of the Journalist in the War on Cancer
|
